Board of Directors

Adam Gickling

Adam Gickling

Adam Gickling is Executive Vice President and Chief Operating Officer at the Bridgewest Group. Adam oversees all aspects of corporate finance and operational strategy. Additionally, he is an active contributor to the operational success of the Bridgewest Group’s portfolio of companies. Through his business acumen and servant leadership style, he fuels a strong multi-talented organizational […]

Adam Gickling Read More »

Tommy Broudy

Dr. Tommy Broudy

Tommy Broudy is a passionate biotech executive with a 20+ year track record building and growing companies in life science tools, diagnostics and therapeutics. Tommy has worked with many companies to create value, set strategy, build teams, establish partnerships, achieve milestones, and generate successful outcomes for all stakeholders. Tommy was part of the leadership team

Dr. Tommy Broudy Read More »

Mike Cicio

Mike Cicio has worked in the Biotechnology Industry for over 30 years as a hands-on executive with experience with both world class innovators and CDMOs. Experienced in general management of clinical and commercial biotechnology business with a focus on operations. Mike has extensive experience in a variety of biotechnology platforms. Mike received a BS in

Mike Cicio Read More »

Rick Hancock, Director

Rick Hancock

Rick Hancock was appointed to the Board of Directors as Executive Chairman in January 2022. Rick has worked in the Biotechnology Industry for over 35 years, including 20 years with various CDMOs in operational and executive roles. Most recently, he served as Interim President and CEO at Avid Bioservices and prior to that, as President

Rick Hancock Read More »